PMS2 and neoplasm: Of the 1,413 patients with a recorded dMMR/MSI test result, 16% had dMMR tumours (13% MLH1 and PMS2 loss, 1% MSH2 and MSH6 loss, 1% PMS2 loss only, < 1% MSH6 loss only, none MSI only).